v3.26.1
Other intangible assets (Details 2)
₨ in Millions
12 Months Ended
Mar. 31, 2026
INR (₨)
Haleon UK Enterprises Limited [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity Consumer Healthcare Portfolio of Nicotine Replacement Therapy
Intangible assets material to entity ₨ 58,245
Wockhardt Limited [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity Select portfolio of branded generics business
Intangible assets material to entity ₨ 10,022
Shanghai Henlius Biotechz,Inc [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity daratamumab biosimilar HLX 15
Intangible assets material to entity ₨ 5,500
Janssen Pharmaceutica NV [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity Antivertigo Brand Stugeron® in India
Intangible assets material to entity ₨ 4,350
Mercury Pharma Group Limited [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity Progynova® and Cyclo-Progynova® in India
Intangible assets material to entity ₨ 3,014
Novartis AG [Member]  
Disclosure of intangible assets material to entity [line items]  
Description of intangible assets material to entity Cardiovascular brand Cidmus® in India
Intangible assets material to entity ₨ 4,005